Public-plan records, documented services and the questions the available sources cannot settle.
What this page answers
Semaglutide for diabetes on the public plan: Yukon national pharmacare programme (no-cost list) excludes GLP-1 agents including Ozempic.
Services documented as offered in Yukon: 0 of 7 checked, on the companies' own pages.
Public care route observed: Maple names Yukon on its assessment landing page.
Evidence depth: programme-level onlyDepth describes the research scope, not coverage and not clinical quality.
Public coverage record
Evidence depth: programme-level onlyProgramme-level only: the plan pages were read, but no product-level benefit list was extracted. Every product-level cell is not researched.
Public plan record for Yukon, as read from the documents named below
Semaglutide for type 2 diabetes (public plan)
Yukon national pharmacare programme (no-cost list) excludes GLP-1 agents including Ozempic; other Yukon Pharmacare and Chronic Disease programmes may apply, product rules not extracted
Weight-management products (public plan)
not researched
Imcivree for rare genetic obesity
not researched
Generic interchangeability with Ozempic
not researched
Source document date
Programme page current 2026 (accessed 2026-09-16)
Public care route observed
Maple names Yukon on its assessment landing page (R22-C32); no other service verified
A listing is not a decision about an individual claim. Criteria, special authorization and the plan's own process still apply.
Services that mention Yukon
Seven services were checked. Each record is what the company's own pages said on the access date.
Documented matches, in alphabetical order
The company's own page names this jurisdiction for its weight service on the access date. Company self-report is not a licence check and not a quality signal.
None in this group
No service documented this jurisdiction in the sources checked. That is not the same as nothing being available.
Confirm availability before relying on it
These records are conflicting, not found in the sources checked, explicitly not offered, not applicable or not researched. They are never mixed in with matches.
Doctor/NP assessment, ongoing reviews and renewals
Conflicting
Three Maple pages disagree. Help page (17 Apr 2026): all locations except NS, NU, NT. Assessment landing page: AB, BC, MB, NB, NL, ON, PEI, QC, SK, Yukon. Obesity page: complimentary assessment in Ontario only. Only ON appears on all three. Display as a dated conflict. R22-C32R22-C33A-C34R41-C19R41-C20R41-C21
Recorded state, as written in the data
conflicting (help page and assessment page name it; obesity page says Ontario only)
Operator
Maple Corporation
Initial care fee, as displayed
Covered by membership (help page); Ontario only per obesity page (conflicting)
Recurring care fee, as displayed
General membership $85/month outside QC; $95/month QC
Referral to specialist; groups and continuing physician support
Not applicable
MSP-covered program for BC residents, virtual or clinic visits, physician referral required. No other province named on checked pages; a BC MSP program is not applicable outside BC. R22-C71R22-C72B-C14aR41-C68
Recorded state, as written in the data
not applicable (BC MSP program)
Operator
Legal operator not found; OMDI/Medical Weight Management branding
Weight service list is six provinces. The general platform list adds NS and NL for other categories only; treat NS and NL as explicitly not offered for weight. Territories and QC, NB not named on either list. R22-C02R22-C04R41-C01R41-C02
Recorded state, as written in the data
not found in sources checked
Operator
Felix Inc.; Felix Health Inc. also appears
Initial care fee, as displayed
Main free; funnel $99
Recurring care fee, as displayed
$40 follow-up
Source 2026-09-16 (page said updated yesterday on 2026-09-17)Accessed 2026-09-23
Weight page FAQ says all Canadian provinces. Territories not named. Wording is a blanket statement, not a province-by-province list; keep the label company self-report. R22-C91R41-C51R41-C52
Recorded state, as written in the data
not found in sources checked
Operator
Hims & Hers Canada Inc.
Initial care fee, as displayed
Free in English and French browser views; $99 still in extracted text of both
Recurring care fee, as displayed
Weight-specific fee unknown
Source undated (live page and text extraction differed on consult fee)Accessed 2026-09-23
No weight-service province or territory list found on the three checked pages. Partner pharmacy is an Ontario corporation (ScaleRx), which does not establish prescribing reach. R22-C98R22-C102R41-C75R41-C76R41-C77
Recorded state, as written in the data
not found in sources checked
Operator
Jack and Jill Health Inc.
Initial care fee, as displayed
$0 initial fee (waived), then $59/month; not a free first month
No weight-specific province list found. Platform terms exclude Quebec and describe pharmacy delivery to provinces and territories; delivery reach is not prescribing reach. Pharmacy operators are in BC and ON. R22-C105R22-C106R22-C111R41-C86R41-C87R41-C88
Maple names Yukon on its assessment landing page (R22-C32); no other service verified
Territory. Only programme-level facts were researched. Non-Insured Health Benefits (NIHB) is a separate federal route that this record has not yet mapped at product level. Round 3 research (R3-1 Part 4) is planned to close this. A programme-level record is never shown as product-level coverage.
What this page cannot say yet
Next research step recorded for this jurisdiction: R3-1 Part 4. Recheck assumption: every 30 days for coverage and every 7 days for service pages.
Company self-report: offeredThe company's own page says it offers the service there. This is not a check of licensing or quality.
ConflictingTwo or more of the company's own pages disagree. Both values are shown with their dates.
Not found in sources checkedThe researcher looked and did not find it. This is not the same as not offered.
Explicitly not offeredThe company's page says it does not serve that place.
Not applicableThe service is a public program limited to one province by design.
Not researchedNobody has looked yet.
Sources for this page
Every claim ID below is a row in the evidence ledger. The source date is the date the source itself carries; the access date is when the researcher opened it. A claim with several rows is one claim with several sources, not several confirmations.
This table scrolls sideways.
Source records for every claim cited on this page
Claim
What the source says
Source
Source date
Accessed
Label
A-C30 source 1 of 3
Yukon no-cost national pharmacare excludes GLP-1s while other programmes may apply
